Skip to content
Yog Pharma
Pain and inflammationNSAID (acetic acid derivative)

Diclofenac Sodium is an NSAID (acetic acid derivative) indicated for osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, and topically for joint pain. We supply it to US manufacturers of delayed-release tablets, extended-release tablets and topical gel.

CAS15307-79-6318.1 g/molC14H10Cl2NNaO2
2D structure of Diclofenac Sodium, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 5018304) and FDA’s substance registry

CAS number

15307-79-6

Molecular formula

C14H10Cl2NNaO2

Molecular weight

318.1g/mol

FDA UNII

IUPAC name

sodium 2-[2-(2,6-dichloroanilino)phenyl]acetate

InChIKey

KPHWPUGNDIVLNH-UHFFFAOYSA-M

Appearance
White or slightly yellowish crystalline powder.
Solubility
Sparingly soluble in water at 25 °C.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Used in oral, topical and ophthalmic products, each with its own requirements. Diclofenac potassium and diclofenac epolamine are separate APIs.

On the US market

Reference product
VoltarenNDA 019201
Approved ANDAs
40 with a marketed product
Approved forms and strengths
  • Delayed-release tablet 25 mg, 50 mg, 75 mg
  • Topical solution 1.5%, 2%
  • Topical gel 1%, 3%
  • Ophthalmic solution 0.1%

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com